Sponsor Pipeline

Institut de cancérologie Strasbourg Europe Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
3
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05388500 Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) HER2-positive Breast Cancer Not Yet Recruiting
NCT05698186 Thero2-01S22 in HER2-positive Breast Cancer HER2-positive Breast Cancer Not Yet Recruiting
NCT06477939 Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated… Glioblastoma Not Yet Recruiting
Disease Areas
Breast Cancer (2) HER2-Positive Breast Cancer (2) Glioblastoma (1)
Get alerts when Institut de cancérologie Strasbourg Europe's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free